CDC advisory panel votes to recommend Pfizer boosters for people 65 and older

CDC advisory panel votes to recommend Pfizer boosters for people 65 and older

(NEW YORK) --  The Centers for Disease Control and Prevention's independent advisory panel has unanimously voted to recommend booster doses of Pfizer's COVID vaccine for people aged 65 and older, along with long-term care facility residents, at least six months after their second dose. The panel also voted to recommend…
How the definition of success has changed in COVID fight

How the definition of success has changed in COVID fight

(NEW YORK) -- In the early days of the pandemic, experts kept a close watch on the number of new cases -- one of the key metrics signaling success or failure of public health measures. But with new variants leading to more frequent breakthrough infections, mild COVID-19 cases will likely…